Summary of novel genes

Entity Tier 1 genes Tier 2 genes Tier 3 genes
DLBCL 8 3 0
PMBL 6 8 0
--- config: sankey: showValues: true linkColor: target width: 600 height: 300 nodeAlignment: right prefix: '(' suffix: ' genes)' --- sankey-beta This study, New Tier 1, 6 New Tier 1, PMBL Tier 1, 6 This study, New Tier 2, 8 New Tier 2, PMBL Tier 2, 8 This study, New Tier 3, 0 New Tier 3, PMBL Tier 3, 0 All other PMBL studies, PMBL Tier 1, 40 All other PMBL studies, PMBL Tier 2, 104 All other PMBL studies, PMBL Tier 3, 0

Novel genes reported in this study

Tier 1

New gene DLBCL tier PMBL tier Average variant quality QC outcome
CD83 1 1
CREBBP 1 1
DUSP2 1 1
FOXO1 1 2
IL4R 1 1
MYC 1 2
PIM1 1 1
SGK1 1 1

Tier 2

New gene DLBCL tier PMBL tier Average variant quality QC outcome
BIRC3 2 2
HRNR 2
LPHN3 2
MCL1 2 2 ★ ★ ★ ☆ ☆ PASS
RFTN1 2 2
WDR87 2

Details

Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021. “Characterization of DLBCL with a PMBL Gene Expression Signature.” Blood 138 (2): 136–48. https://doi.org/10.1182/blood.2020007683.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.